James Yarmolinsky1,2, Caroline J Bull1,2,3, Emma E Vincent1,2,3, Jamie Robinson1,2, Axel Walther4, George Davey Smith1,2, Sarah J Lewis1,2, Caroline L Relton1,2, Richard M Martin1,2,5. 1. MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. 2. Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. 3. School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom. 4. Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom. 5. National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Abstract
Importance: Preclinical and epidemiological studies indicate a potential chemopreventive role of statins in epithelial ovarian cancer risk. Objective: To evaluate the association of genetically proxied inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (ie, genetic variants related to lower function of HMG-CoA reductase, target of statins) with epithelial ovarian cancer among the general population and in BRCA1/2 mutation carriers. Design, Setting, and Participants: Single-nucleotide polymorphisms (SNPs) in HMGCR, NPC1L1, and PCSK9 associated with low-density lipoprotein (LDL) cholesterol in a genome-wide association study (GWAS) meta-analysis (N ≤196 475) were used to proxy therapeutic inhibition of HMG-CoA reductase, Niemann-Pick C1-Like 1 (NPC1L1) and proprotein convertase subtilisin/kexin type 9 (PCSK9), respectively. Summary statistics were obtained for these SNPs from a GWAS meta-analysis of case-control analyses of invasive epithelial ovarian cancer in the Ovarian Cancer Association Consortium (OCAC; N = 63 347) and from a GWAS meta-analysis of retrospective cohort analyses of epithelial ovarian cancer among BRCA1/2 mutation carriers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA; N = 31 448). Across the 2 consortia, participants were enrolled between 1973 and 2014 and followed up through 2015. OCAC participants came from 14 countries and CIMBA participants came from 25 countries. SNPs were combined into multi-allelic models and mendelian randomization estimates representing lifelong inhibition of targets were generated using inverse-variance weighted random-effects models. Exposures: Primary exposure was genetically proxied inhibition of HMG-CoA reductase and secondary exposures were genetically proxied inhibition of NPC1L1 and PCSK9 and genetically proxied circulating LDL cholesterol levels. Main Outcomes and Measures: Overall and histotype-specific invasive epithelial ovarian cancer (general population) and epithelial ovarian cancer (BRCA1/2 mutation carriers), measured as ovarian cancer odds (general population) and hazard ratio (BRCA1/2 mutation carriers). Results: The OCAC sample included 22 406 women with invasive epithelial ovarian cancer and 40 941 control individuals and the CIMBA sample included 3887 women with epithelial ovarian cancer and 27 561 control individuals. Median ages for the cohorts ranged from 41.5 to 59.0 years and all participants were of European ancestry. In the primary analysis, genetically proxied HMG-CoA reductase inhibition equivalent to a 1-mmol/L (38.7-mg/dL) reduction in LDL cholesterol was associated with lower odds of epithelial ovarian cancer (odds ratio [OR], 0.60 [95% CI, 0.43-0.83]; P = .002). In BRCA1/2 mutation carriers, genetically proxied HMG-CoA reductase inhibition was associated with lower ovarian cancer risk (hazard ratio, 0.69 [95% CI, 0.51-0.93]; P = .01). In secondary analyses, there were no significant associations of genetically proxied inhibition of NPC1L1 (OR, 0.97 [95% CI, 0.53-1.75]; P = .91), PCSK9 (OR, 0.98 [95% CI, 0.85-1.13]; P = .80), or circulating LDL cholesterol (OR, 0.98 [95% CI, 0.91-1.05]; P = .55) with epithelial ovarian cancer. Conclusions and Relevance: Genetically proxied inhibition of HMG-CoA reductase was significantly associated with lower odds of epithelial ovarian cancer. However, these findings do not indicate risk reduction from medications that inhibit HMG-CoA reductase; further research is needed to understand whether there is a similar association with such medications.
Importance: Preclinical and epidemiological studies indicate a potential chemopreventive role of statins in epithelial ovarian cancer risk. Objective: To evaluate the association of genetically proxied inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (ie, genetic variants related to lower function of HMG-CoA reductase, target of statins) with epithelial ovarian cancer among the general population and in BRCA1/2 mutation carriers. Design, Setting, and Participants: Single-nucleotide polymorphisms (SNPs) in HMGCR, NPC1L1, and PCSK9 associated with low-density lipoprotein (LDL) cholesterol in a genome-wide association study (GWAS) meta-analysis (N ≤196 475) were used to proxy therapeutic inhibition of HMG-CoA reductase, Niemann-Pick C1-Like 1 (NPC1L1) and proprotein convertase subtilisin/kexin type 9 (PCSK9), respectively. Summary statistics were obtained for these SNPs from a GWAS meta-analysis of case-control analyses of invasive epithelial ovarian cancer in the Ovarian Cancer Association Consortium (OCAC; N = 63 347) and from a GWAS meta-analysis of retrospective cohort analyses of epithelial ovarian cancer among BRCA1/2 mutation carriers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA; N = 31 448). Across the 2 consortia, participants were enrolled between 1973 and 2014 and followed up through 2015. OCAC participants came from 14 countries and CIMBA participants came from 25 countries. SNPs were combined into multi-allelic models and mendelian randomization estimates representing lifelong inhibition of targets were generated using inverse-variance weighted random-effects models. Exposures: Primary exposure was genetically proxied inhibition of HMG-CoA reductase and secondary exposures were genetically proxied inhibition of NPC1L1 and PCSK9 and genetically proxied circulating LDL cholesterol levels. Main Outcomes and Measures: Overall and histotype-specific invasive epithelial ovarian cancer (general population) and epithelial ovarian cancer (BRCA1/2 mutation carriers), measured as ovarian cancer odds (general population) and hazard ratio (BRCA1/2 mutation carriers). Results: The OCAC sample included 22 406 women with invasive epithelial ovarian cancer and 40 941 control individuals and the CIMBA sample included 3887 women with epithelial ovarian cancer and 27 561 control individuals. Median ages for the cohorts ranged from 41.5 to 59.0 years and all participants were of European ancestry. In the primary analysis, genetically proxied HMG-CoA reductase inhibition equivalent to a 1-mmol/L (38.7-mg/dL) reduction in LDL cholesterol was associated with lower odds of epithelial ovarian cancer (odds ratio [OR], 0.60 [95% CI, 0.43-0.83]; P = .002). In BRCA1/2 mutation carriers, genetically proxied HMG-CoA reductase inhibition was associated with lower ovarian cancer risk (hazard ratio, 0.69 [95% CI, 0.51-0.93]; P = .01). In secondary analyses, there were no significant associations of genetically proxied inhibition of NPC1L1 (OR, 0.97 [95% CI, 0.53-1.75]; P = .91), PCSK9 (OR, 0.98 [95% CI, 0.85-1.13]; P = .80), or circulating LDL cholesterol (OR, 0.98 [95% CI, 0.91-1.05]; P = .55) with epithelial ovarian cancer. Conclusions and Relevance: Genetically proxied inhibition of HMG-CoA reductase was significantly associated with lower odds of epithelial ovarian cancer. However, these findings do not indicate risk reduction from medications that inhibit HMG-CoA reductase; further research is needed to understand whether there is a similar association with such medications.
Authors: Lindsey A Torre; Britton Trabert; Carol E DeSantis; Kimberly D Miller; Goli Samimi; Carolyn D Runowicz; Mia M Gaudet; Ahmedin Jemal; Rebecca L Siegel Journal: CA Cancer J Clin Date: 2018-05-29 Impact factor: 508.702
Authors: William H Parker; Michael S Broder; Eunice Chang; Diane Feskanich; Cindy Farquhar; Zhimae Liu; Donna Shoupe; Jonathan S Berek; Susan Hankinson; JoAnn E Manson Journal: Obstet Gynecol Date: 2009-05 Impact factor: 7.661
Authors: Babatunde Akinwunmi; Allison F Vitonis; Linda Titus; Kathryn L Terry; Daniel W Cramer Journal: Int J Cancer Date: 2018-10-30 Impact factor: 7.396
Authors: William H Parker; Diane Feskanich; Michael S Broder; Eunice Chang; Donna Shoupe; Cynthia M Farquhar; Jonathan S Berek; JoAnn E Manson Journal: Obstet Gynecol Date: 2013-04 Impact factor: 7.661
Authors: John Rb Perry; Felix Day; Cathy E Elks; Patrick Sulem; Kari Stefansson; Joanne M Murabito; Ken K Ong; Deborah J Thompson; Teresa Ferreira; Chunyan He; Daniel I Chasman; Tõnu Esko; Gudmar Thorleifsson; Eva Albrecht; Wei Q Ang; Tanguy Corre; Diana L Cousminer; Bjarke Feenstra; Nora Franceschini; Andrea Ganna; Andrew D Johnson; Sanela Kjellqvist; Kathryn L Lunetta; George McMahon; Ilja M Nolte; Lavinia Paternoster; Eleonora Porcu; Albert V Smith; Lisette Stolk; Alexander Teumer; Natalia Tšernikova; Emmi Tikkanen; Sheila Ulivi; Erin K Wagner; Najaf Amin; Laura J Bierut; Enda M Byrne; Jouke-Jan Hottenga; Daniel L Koller; Massimo Mangino; Tune H Pers; Laura M Yerges-Armstrong; Jing Hua Zhao; Irene L Andrulis; Hoda Anton-Culver; Femke Atsma; Stefania Bandinelli; Matthias W Beckmann; Javier Benitez; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Bernardo Bonanni; Hiltrud Brauch; Hermann Brenner; Julie E Buring; Jenny Chang-Claude; Stephen Chanock; Jinhui Chen; Georgia Chenevix-Trench; J Margriet Collée; Fergus J Couch; David Couper; Andrea D Coveillo; Angela Cox; Kamila Czene; Adamo Pio D'adamo; George Davey Smith; Immaculata De Vivo; Ellen W Demerath; Joe Dennis; Peter Devilee; Aida K Dieffenbach; Alison M Dunning; Gudny Eiriksdottir; Johan G Eriksson; Peter A Fasching; Luigi Ferrucci; Dieter Flesch-Janys; Henrik Flyger; Tatiana Foroud; Lude Franke; Melissa E Garcia; Montserrat García-Closas; Frank Geller; Eco Ej de Geus; Graham G Giles; Daniel F Gudbjartsson; Vilmundur Gudnason; Pascal Guénel; Suiqun Guo; Per Hall; Ute Hamann; Robin Haring; Catharina A Hartman; Andrew C Heath; Albert Hofman; Maartje J Hooning; John L Hopper; Frank B Hu; David J Hunter; David Karasik; Douglas P Kiel; Julia A Knight; Veli-Matti Kosma; Zoltan Kutalik; Sandra Lai; Diether Lambrechts; Annika Lindblom; Reedik Mägi; Patrik K Magnusson; Arto Mannermaa; Nicholas G Martin; Gisli Masson; Patrick F McArdle; Wendy L McArdle; Mads Melbye; Kyriaki Michailidou; Evelin Mihailov; Lili Milani; Roger L Milne; Heli Nevanlinna; Patrick Neven; Ellen A Nohr; Albertine J Oldehinkel; Ben A Oostra; Aarno Palotie; Munro Peacock; Nancy L Pedersen; Paolo Peterlongo; Julian Peto; Paul Dp Pharoah; Dirkje S Postma; Anneli Pouta; Katri Pylkäs; Paolo Radice; Susan Ring; Fernando Rivadeneira; Antonietta Robino; Lynda M Rose; Anja Rudolph; Veikko Salomaa; Serena Sanna; David Schlessinger; Marjanka K Schmidt; Mellissa C Southey; Ulla Sovio; Meir J Stampfer; Doris Stöckl; Anna M Storniolo; Nicholas J Timpson; Jonathan Tyrer; Jenny A Visser; Peter Vollenweider; Henry Völzke; Gerard Waeber; Melanie Waldenberger; Henri Wallaschofski; Qin Wang; Gonneke Willemsen; Robert Winqvist; Bruce Hr Wolffenbuttel; Margaret J Wright; Dorret I Boomsma; Michael J Econs; Kay-Tee Khaw; Ruth Jf Loos; Mark I McCarthy; Grant W Montgomery; John P Rice; Elizabeth A Streeten; Unnur Thorsteinsdottir; Cornelia M van Duijn; Behrooz Z Alizadeh; Sven Bergmann; Eric Boerwinkle; Heather A Boyd; Laura Crisponi; Paolo Gasparini; Christian Gieger; Tamara B Harris; Erik Ingelsson; Marjo-Riitta Järvelin; Peter Kraft; Debbie Lawlor; Andres Metspalu; Craig E Pennell; Paul M Ridker; Harold Snieder; Thorkild Ia Sørensen; Tim D Spector; David P Strachan; André G Uitterlinden; Nicholas J Wareham; Elisabeth Widen; Marek Zygmunt; Anna Murray; Douglas F Easton Journal: Nature Date: 2014-07-23 Impact factor: 49.962
Authors: Cristen J Willer; Ellen M Schmidt; Sebanti Sengupta; Michael Boehnke; Panos Deloukas; Sekar Kathiresan; Karen L Mohlke; Erik Ingelsson; Gonçalo R Abecasis; Gina M Peloso; Stefan Gustafsson; Stavroula Kanoni; Andrea Ganna; Jin Chen; Martin L Buchkovich; Samia Mora; Jacques S Beckmann; Jennifer L Bragg-Gresham; Hsing-Yi Chang; Ayşe Demirkan; Heleen M Den Hertog; Ron Do; Louise A Donnelly; Georg B Ehret; Tõnu Esko; Mary F Feitosa; Teresa Ferreira; Krista Fischer; Pierre Fontanillas; Ross M Fraser; Daniel F Freitag; Deepti Gurdasani; Kauko Heikkilä; Elina Hyppönen; Aaron Isaacs; Anne U Jackson; Åsa Johansson; Toby Johnson; Marika Kaakinen; Johannes Kettunen; Marcus E Kleber; Xiaohui Li; Jian'an Luan; Leo-Pekka Lyytikäinen; Patrik K E Magnusson; Massimo Mangino; Evelin Mihailov; May E Montasser; Martina Müller-Nurasyid; Ilja M Nolte; Jeffrey R O'Connell; Cameron D Palmer; Markus Perola; Ann-Kristin Petersen; Serena Sanna; Richa Saxena; Susan K Service; Sonia Shah; Dmitry Shungin; Carlo Sidore; Ci Song; Rona J Strawbridge; Ida Surakka; Toshiko Tanaka; Tanya M Teslovich; Gudmar Thorleifsson; Evita G Van den Herik; Benjamin F Voight; Kelly A Volcik; Lindsay L Waite; Andrew Wong; Ying Wu; Weihua Zhang; Devin Absher; Gershim Asiki; Inês Barroso; Latonya F Been; Jennifer L Bolton; Lori L Bonnycastle; Paolo Brambilla; Mary S Burnett; Giancarlo Cesana; Maria Dimitriou; Alex S F Doney; Angela Döring; Paul Elliott; Stephen E Epstein; Gudmundur Ingi Eyjolfsson; Bruna Gigante; Mark O Goodarzi; Harald Grallert; Martha L Gravito; Christopher J Groves; Göran Hallmans; Anna-Liisa Hartikainen; Caroline Hayward; Dena Hernandez; Andrew A Hicks; Hilma Holm; Yi-Jen Hung; Thomas Illig; Michelle R Jones; Pontiano Kaleebu; John J P Kastelein; Kay-Tee Khaw; Eric Kim; Norman Klopp; Pirjo Komulainen; Meena Kumari; Claudia Langenberg; Terho Lehtimäki; Shih-Yi Lin; Jaana Lindström; Ruth J F Loos; François Mach; Wendy L McArdle; Christa Meisinger; Braxton D Mitchell; Gabrielle Müller; Ramaiah Nagaraja; Narisu Narisu; Tuomo V M Nieminen; Rebecca N Nsubuga; Isleifur Olafsson; Ken K Ong; Aarno Palotie; Theodore Papamarkou; Cristina Pomilla; Anneli Pouta; Daniel J Rader; Muredach P Reilly; Paul M Ridker; Fernando Rivadeneira; Igor Rudan; Aimo Ruokonen; Nilesh Samani; Hubert Scharnagl; Janet Seeley; Kaisa Silander; Alena Stančáková; Kathleen Stirrups; Amy J Swift; Laurence Tiret; Andre G Uitterlinden; L Joost van Pelt; Sailaja Vedantam; Nicholas Wainwright; Cisca Wijmenga; Sarah H Wild; Gonneke Willemsen; Tom Wilsgaard; James F Wilson; Elizabeth H Young; Jing Hua Zhao; Linda S Adair; Dominique Arveiler; Themistocles L Assimes; Stefania Bandinelli; Franklyn Bennett; Murielle Bochud; Bernhard O Boehm; Dorret I Boomsma; Ingrid B Borecki; Stefan R Bornstein; Pascal Bovet; Michel Burnier; Harry Campbell; Aravinda Chakravarti; John C Chambers; Yii-Der Ida Chen; Francis S Collins; Richard S Cooper; John Danesh; George Dedoussis; Ulf de Faire; Alan B Feranil; Jean Ferrières; Luigi Ferrucci; Nelson B Freimer; Christian Gieger; Leif C Groop; Vilmundur Gudnason; Ulf Gyllensten; Anders Hamsten; Tamara B Harris; Aroon Hingorani; Joel N Hirschhorn; Albert Hofman; G Kees Hovingh; Chao Agnes Hsiung; Steve E Humphries; Steven C Hunt; Kristian Hveem; Carlos Iribarren; Marjo-Riitta Järvelin; Antti Jula; Mika Kähönen; Jaakko Kaprio; Antero Kesäniemi; Mika Kivimaki; Jaspal S Kooner; Peter J Koudstaal; Ronald M Krauss; Diana Kuh; Johanna Kuusisto; Kirsten O Kyvik; Markku Laakso; Timo A Lakka; Lars Lind; Cecilia M Lindgren; Nicholas G Martin; Winfried März; Mark I McCarthy; Colin A McKenzie; Pierre Meneton; Andres Metspalu; Leena Moilanen; Andrew D Morris; Patricia B Munroe; Inger Njølstad; Nancy L Pedersen; Chris Power; Peter P Pramstaller; Jackie F Price; Bruce M Psaty; Thomas Quertermous; Rainer Rauramaa; Danish Saleheen; Veikko Salomaa; Dharambir K Sanghera; Jouko Saramies; Peter E H Schwarz; Wayne H-H Sheu; Alan R Shuldiner; Agneta Siegbahn; Tim D Spector; Kari Stefansson; David P Strachan; Bamidele O Tayo; Elena Tremoli; Jaakko Tuomilehto; Matti Uusitupa; Cornelia M van Duijn; Peter Vollenweider; Lars Wallentin; Nicholas J Wareham; John B Whitfield; Bruce H R Wolffenbuttel; Jose M Ordovas; Eric Boerwinkle; Colin N A Palmer; Unnur Thorsteinsdottir; Daniel I Chasman; Jerome I Rotter; Paul W Franks; Samuli Ripatti; L Adrienne Cupples; Manjinder S Sandhu; Stephen S Rich Journal: Nat Genet Date: 2013-10-06 Impact factor: 38.330
Authors: Mark Gormley; James Yarmolinsky; Tom Dudding; Kimberley Burrows; Richard M Martin; Steven Thomas; Jessica Tyrrell; Paul Brennan; Miranda Pring; Stefania Boccia; Andrew F Olshan; Brenda Diergaarde; Rayjean J Hung; Geoffrey Liu; Danny Legge; Eloiza H Tajara; Patricia Severino; Martin Lacko; Andrew R Ness; George Davey Smith; Emma E Vincent; Rebecca C Richmond Journal: PLoS Genet Date: 2021-04-22 Impact factor: 5.917
Authors: Michael V Holmes; Tom G Richardson; Brian A Ference; Neil M Davies; George Davey Smith Journal: Nat Rev Cardiol Date: 2021-03-11 Impact factor: 32.419
Authors: Aayah Nounu; Alexander Greenhough; Kate J Heesom; Rebecca C Richmond; Jie Zheng; Stephanie J Weinstein; Demetrius Albanes; John A Baron; John L Hopper; Jane C Figueiredo; Polly A Newcomb; Noralane M Lindor; Graham Casey; Elizabeth A Platz; Loïc Le Marchand; Cornelia M Ulrich; Christopher I Li; Fränzel J B van Duijnhoven; Andrea Gsur; Peter T Campbell; Víctor Moreno; Pavel Vodicka; Ludmila Vodickova; Hermann Brenner; Jenny Chang-Claude; Michael Hoffmeister; Lori C Sakoda; Martha L Slattery; Robert E Schoen; Marc J Gunter; Sergi Castellví-Bel; Hyeong Rok Kim; Sun-Seog Kweon; Andrew T Chan; Li Li; Wei Zheng; D Timothy Bishop; Daniel D Buchanan; Graham G Giles; Stephen B Gruber; Gad Rennert; Zsofia K Stadler; Tabitha A Harrison; Yi Lin; Temitope O Keku; Michael O Woods; Clemens Schafmayer; Bethany Van Guelpen; Steven Gallinger; Heather Hampel; Sonja I Berndt; Paul D P Pharoah; Annika Lindblom; Alicja Wolk; Anna H Wu; Emily White; Ulrike Peters; David A Drew; Dominique Scherer; Justo Lorenzo Bermejo; Ann C Williams; Caroline L Relton Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-12-14 Impact factor: 4.090
Authors: Shaimaa M Badr-Eldin; Nabil A Alhakamy; Usama A Fahmy; Osama A A Ahmed; Hani Z Asfour; Abdulhamid A Althagafi; Hibah M Aldawsari; Waleed Y Rizg; Wael A Mahdi; Adel F Alghaith; Sultan Alshehri; Filippo Caraci; Giuseppe Caruso Journal: Front Pharmacol Date: 2021-02-03 Impact factor: 5.810
Authors: Daniel P C Considine; Guochong Jia; Xiang Shu; Joellen M Schildkraut; Paul D P Pharoah; Wei Zheng; Siddhartha P Kar Journal: Gynecol Oncol Date: 2020-11-25 Impact factor: 5.482